Orelabrutinib, An Irreversible Inhibitor Of Bruton'S Tyrosine Kinase, For Treatment Of Primary Immune Thrombocytopenia: Results Of A Randomized, Open-Label Phase Ii Study
Orelabrutinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Orelabrutinib, An Irreversible Inhibitor Of Bruton'S Tyrosine Kinase, For Treatment Of Primary Immune Thrombocytopenia: Results Of A Randomized, Open-Label Phase Ii Study ### Output: Orelabrutinib